ProfessorRasha Al-Lamee

Professor Rasha Al-Lamee is an Clinical Academic Interventional Cardiology Consultant at Imperial College Healthcare NHS Trust in London, UK. She is a British Heart Foundation Intermediate Research Fellow and a Professor of Cardiology at Imperial College London. Prof Al-Lamee’s research interests are complex coronary intervention, coronary physiology and invasive intravascular assessment.

She designed, conducted and led the ORBITA trial and is lead author of the primary publication in the Lancet and 3 secondary publications in Circulation and European Heart Journal. She is the Chief Investigator of the ORBITA-2 trial, published in New England Journal of Medicine in 2023 with a secondary publications in JACC and Circulation, the ORBITA-COSMIC trial (Lancet 2024), the ORBITA-STAR (JACC 2024) and ORBITA-FIRE (Circulation 2026). She led The Lancet commssion on atherosclerotic heart disease (Lancet 2025). She is currently leading the ORBITA-SOLAR and ORBITA-MOON trials. At Imperial College London she is actively involved in the development and recruitment for a number of multi-centre clinical trials. Prof Al-Lamee has over 200 peer-reviewed publications and has presented at international Cardiology conferences worldwide throughout her clinical career. She is actively involved in the development and recruitment for many multi-centre international clinical trials.

She studied at the University of Oxford and University College London. She completed her training in clinical cardiology on the North West London Cardiology rotation in 2013 and completed her PhD at Imperial College London in 2018.

Prof Al-Lamee has over 16 years of Cardiology experience and completed three years of Interventional Fellowship training at Hammersmith Hospital in London. She also spent a year training as an Interventional Fellow under the supervision of Professor Antonio Colombo in Milan. She completed specialist training in Cardiology in 2013.

She is a deputy editor at JACC. She is the co-director of the cardiovascular theme of the Imperial Biomedical Research Centre and head of the second year and a Deputy Director of MB BS Medicine at Imperial College London.